| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 285,230 | 260,594 | 251,142 | 268,809 | | Cost of Revenue | 138,835 | 111,538 | 109,007 | 106,765 | | | Gross Profit | 146,395 | 149,056 | 142,135 | 162,044 | | | Operating Expenses | | Research Development | 7,737 | 10,063 | 7,232 | 9,190 | | Selling General and Administrative | 100,038 | 93,705 | 94,992 | 101,256 | | Non Recurring | 462 |
-
| 2,954 |
-
| | Others | 4,233 | 4,080 | 4,177 | 4,096 | | | | Total Operating Expenses | 112,470 |
-
| 109,355 |
-
| | | | Operating Income or Loss | 33,925 | 41,208 | 32,780 | 47,502 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (155) | 259 | 8,145 | (1,901) | | Earnings Before Interest And Taxes | 33,770 | 41,467 | 40,925 | 45,601 | | Interest Expense | 11,085 | 10,830 | 11,457 | 12,343 | | Income Before Tax | 22,685 | 30,637 | 29,468 | 33,258 | | Income Tax Expense | 777 | 5,988 | 5,595 | 3,779 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 21,908 | 24,649 | 23,873 | 29,479 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 21,908 | 24,649 | 23,873 | 29,479 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $21,908 | $24,649 | $23,873 | $29,479 |
|
0.49% Nasdaq 
Income Statement
